S&P 500 7691.31 -0.35%
NASDAQ 26466.03 -0.15%
TASI 11036.25 +0.10%
Oil (WTI) 92.28 +0.87%
Oil (Brent) 97.11 +0.86%
VIX 15.34 +5.57%
Gold 4432.10 -0.99%
USD/SAR 3.75 -0.01%

Medtronic plc

MDT · Healthcare · · USD
92.44 USD
0.00 (-1.83%)
● Updated 2026-09-08 21:04 Saudi Time ↻ Refresh
Short-term Mid-term Long-term

Fahodi Score HOLD Long-term (Investment)

64
/ 100
Technical 50
Trend & RS 67
Momentum 66
Fundamental 78
Macro 65
Liquidity 44
ComponentScoreWeight
Technical 50.0 10%
Trend & RS 66.6 10%
Momentum 65.6 5%
Fundamental 77.8 40%
Macro 64.7 15%
Liquidity 43.8 20%

Trade Setup

Entry 92.48
Stop Loss 87.84 (5.0%)
Target 1 (1:1) 97.12 (+5.0%)
Target 2 (2:1) 101.76 (+10.0%)
ATR(14) 2.32 (2.5%)
Risk per Share 4.64
Reward:Risk 2:1

ATR-based levels. Adjust for support/resistance zones.

Factor Profile

Factor Score Z Bar
Value 70.3 +0.81
Momentum 65.6 +0.62
Quality 44.6 -0.21
Composite 60.2

Quality Scores

Piotroski F-Score 7 /9 — Strong
1. Positive Net Income 2. Positive Roa 3. Positive Cfo 4. Quality Earnings 5. Lower Leverage 6. Higher Liquidity 7. No Dilution 8. Higher Gross Margin 9. Higher Asset Turnover
Altman Z-Score Insufficient Data

Valuation vs Peers Undervalued

MetricStockSectorvs Peers
P/E Ratio 22.8 22.0 Inline
P/B Ratio 2.4 4.0 Below
Dividend Yield 3.1% 1.5% Above avg

Comparing against Healthcare median multiples.

Trading at a discount to sector peers — potential value opportunity.

Intrinsic Value (DCF) Overvalued

Intrinsic Value
81.72
vs
Market Price
92.44
Upside
-11.6%
Margin of Safety -13.1%
Stage 1 PV (5yr FCF)23,619,950,463
Terminal Value PV80,912,149,941
Total Enterprise Value104,532,100,404

Assumptions

Base FCF4,154,640,005
Growth Rate (5yr)13.7%
Terminal Growth2.5%
Discount Rate (WACC)9.0%

2-stage DCF: 5yr projected FCF + Gordon Growth terminal value. Estimates only — adjust growth and WACC for your own assumptions.

Position Sizing — Kelly Criterion

4.5%
Recommended Size
42.35%
Full Kelly
21.17%
Half Kelly
5.0%
Max Cap (Moderate)

Kelly inputs derived from quant score 64/100. Estimated win rate 59%, avg win 8.9%, avg loss 3.7%. Position was capped at the moderate risk maximum. This is analytical output, not a recommendation to trade.

BEAR Regime: BEAR (20% confidence) — position size reduced 10%

Signal Summary BUY

2
Bullish Signals
2
Bearish Signals
57.51
RSI(14)
1.6352
MACD

Relative Strength (RS) NEUTRAL

41
/ 99
RS Rating
O'Neil filter: <80
RS vs SPY ↑ RISING (+11.9% vs SPY 3M)
RS vs Sector OUTPERFORMING (Healthcare)
RS New High Near 3-month high 13d since high
Sector Outperformance +4.8% (3M)
RS Line — stock / SPY (90 bars)
← older newer →
RS vs SPY 50-day SMA of RS
NEUTRAL: In line with the market — no strong outperformance or underperformance.

Technical Indicators

IndicatorValueSignal
Rsi 57.51 NEUTRAL
Macd 1.6352 BEARISH
Ma Cross 86.97 / 88.64 DEATH CROSS
Trend Short ABOVE SMA50
Trend Long ABOVE SMA200
Bollinger MIDDLE
Volume 0.47x LOW

Key Levels

LevelPrice
52-Week High106.33
Bollinger Upper94.32
SMA(200)88.64
SMA(50)86.97
SMA(20)91.88
Current Price92.44
Bollinger Lower89.44
52-Week Low73.31
ATR(14)2.32

Advanced Technical Analysis

Click to expand

Wyckoff Phase & Volume Spread Analysis

Wyckoff Phase

DISTRIBUTION C Confidence
56%
Upthrust (potential)
Acc: 0.0  |  Dist: 2.5  |  Markup: 2.0  |  Markdown: 0.0

Volume Spread Analysis (last 5 bars)

DateSignalVolDescription
2026-09-01 Upthrust 2.4x High volume up-bar closing near low — failed breakout (Upthrust)
2026-09-02 Normal 1.16x Normal bar — no special VSA pattern
2026-09-03 Normal 0.94x Normal bar — no special VSA pattern
2026-09-04 Normal 1.15x Normal bar — no special VSA pattern
2026-09-08 Normal 0.47x Normal bar — no special VSA pattern

Ichimoku Cloud BULLISH

LineValueStatus
Tenkan-sen (9) 92.67 Above Kijun
Kijun-sen (26) 90.18 Base line
Senkou A 91.43 Leading span A
Senkou B 86.78 Leading span B
Cloud 86.78 – 91.43 Bullish (Green)
Price vs Cloud 92.48 Above Cloud
Chikou Span 86.68 Bullish
Alignment Score 4/4 BULLISH

TTM Squeeze & Divergences

TTM Squeeze

SQUEEZE ON 3 bars Momentum: BULLISH FADING
BB: 89.44 – 94.32  |  KC: 88.58 – 95.19

Divergences (last 60 bars)

TypeIndicatorBars AgoStrength
Hidden Bullish RSI 8
Hidden Bullish MACD 8

Anchored VWAP

VWAP: 84.23 Anchor: 2026-06-02 (52w Low) ABOVE AVWAP +9.8%

Heikin-Ashi Trend

WEAKLY BEARISH Full data via /api/advanced/MDT

Valuation

MetricValue
Market Cap118.25B
P/E (TTM)22.77
Forward P/EN/A
P/B2.39
EPS4.06

Financial Health

MetricValue
Revenue Growth13.7%
Profit Margin13.9%
ROE10.6%
Debt/Equity55.37
Current Ratio2.07
Dividend Yield3.1%
Payout RatioN/A
Beta0.57

Trading Data

92.44
Open
92.44
Day High
92.44
Day Low
3.55M
Volume (0.4x avg)

Recent News (8)

S&P 500 Second Quarter Earnings Outpace Forecast as Reporting Season Nears End, Oppenheimer Says
MT Newswires · 2026-09-08
Is Medtronic Worth Buying as Growth Improves but Risks Stay Elevated?
Zacks · 2026-09-08
Medtronic (MDT) Q1 2027 Earnings Call Transcript
Motley Fool · 2026-09-08
ISRG's Ion Platform Is Quietly Becoming a Second Growth Engine
Zacks · 2026-09-07
How Much Upside Can BSX Stock's Growth Deliver?
Trefis · 2026-09-04
Was JNJ Stock Rally Actually Its Own?
Trefis · 2026-09-04
Boston Scientific's ICVT Business Gains Momentum: Can Growth Continue?
Zacks · 2026-09-04
4 Reasons to Buy Medtronic Stock Like There's No Tomorrow
Motley Fool · 2026-09-03

Price Chart (90 Days)

Candlesticks (green=up, red=down) SMA 20 SMA 50 Bollinger Bands (upper/lower) Volume (green=buying, red=selling)
Powered by Fahodi Methodology. This is analytical output, not financial advice. Always do your own due diligence.  ·  Pipeline status  ·  Data: —